WilmerHale Achieves Trial Victory for Reckitt Benckiser

WilmerHale Achieves Trial Victory for Reckitt Benckiser

Client News

Related Solutions

Providing effective, creative and efficient representation for clients’ most complex commercial disputes.
Clients trust us to protect their most important intellectual property matters.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Battle-tested. Globally Respected.

A WilmerHale team, working closely with lawyers from Sheppard Mullin, secured a major victory for client Reckitt Benckiser following a jury trial in the District of New Jersey. The jury rejected claims brought by Absorption Pharmaceuticals, which sought $454 million in damages for alleged fraud and trade secret misappropriation. Absorption’s claims arose from Reckitt’s 2014-2015 evaluation of a potential transaction involving Absorption’s product Promescent and Reckitt’s 2016 launch of its product K-Y Duration.

The finding of no liability follows over five years of litigation, including multiple COVID-related delays, and testimony from 14 live witnesses during the four-week jury trial.

The WilmerHale team representing Reckitt Benckiser was led by Robert Gunther, Hallie Levin and Peter Neiman and included Jason Liss, Stephanie Lin, Alex Miller and Paul Vanderslice.

 

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel